019736 S387 M5 c4591012 interim sponsor signature

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

1

Document text

APPENDIX  1. SIGNATURES  
 
PROTOCOL  NUMBER:  C4591012  
TITLE  OF STUDY:  Post-Emergency Use Authorization Active  
Safety  Surveillance  Study  among  Individuals  in 
the Veteran’s Affairs Health System Receiving  
Pfizer -BioNTech Coronavirus Disease 2019  
(COVID -19) Vaccine  
FINAL  STUDY  REPORT  VERSION:  1.0 
 
Confirmation: I confirm that this non -interventional (NI) study final report, which is  
final in content and has been printed from its definitive source, is a complete and  
accurate representation  of the data  and statistical  analyses from this  study.  
 
Pfizer  NI study  lead 
Cynthia  de Luise, PhD,  MPH   
 
Signature:   
Date:   June 22, 2021  
 
 
Co-Investigator  
Managing Principal and Chief Epidemiologist, Analysis Group, Inc.  
Mei Sheng Duh, ScD, MPH  
 
Signature:  Date:  June  17, 2021  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PFIZER  CONFIDENTIAL  
CT24 -WI-GL15 -RF06  1.0 Non-Interventional  Study  Report/Manuscript  Signatures  15-Aug-2018  
Page  1 of 1 
C4591012  
090177e1975ed860\Approved\Approved On: 22-Jun-2021 17:33 (GMT) 
FDA-CBER-2021-5683-1076202